Vincent Medical Holdings Limited stock analysis
Want to see HK:1612 full AI Analyst Report?
Vincent Medical Holdings Limited (1612) Stock Price & Analysis
1612 Stock Chart & Stats
- Day’s Range
- HKD 0.68 - HKD 0.69
- 52-Week Range
- HKD 0.64 - HKD 1.09
- Previous Close
- HKD 0.69
- Volume
- N/A
- Average Volume (3M)
- 95.64K
- Market Cap
- HKD 452.17M
- Enterprise Value
- HKD 531.91M
- Total Cash (Recent Filing)
- HKD 199.93M
- Total Debt (Recent Filing)
- HKD 240.66M
- Price to Earnings (P/E)
- 4.6
- Beta
- 0.78
- Next Earnings
- Mar 24, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 08, 2026
- Dividend Yield
- 6.76%
Bulls Say, Bears Say
Bulls Say
Revenue And Margin Recovery
The return to multi-year revenue growth, combined with materially higher gross and net margins in 2025, indicates improving operating performance. If this recovery persists, it can strengthen internal funding capacity and support a more durable earnings base over the next several quarters.
Manageable Leverage
Debt remains moderate relative to equity, giving the company meaningful financial flexibility compared with a highly leveraged business. Growing equity and improved returns also indicate better capital productivity, supporting resilience and the ability to fund operations without excessive balance-sheet strain.
Operating Cash Flow Rebound
The sharp improvement in operating cash flow and return to positive free cash flow show that the recent earnings recovery is producing more cash than in 2024. This improves liquidity for investment, working-capital needs, and shareholder distributions, even though conversion remains imperfect.
Bears Say
Weak Free Cash Flow Conversion
Low conversion of reported profit into free cash flow means earnings quality remains weaker than the income statement alone suggests. Persistent conversion pressure could limit internally funded expansion and shareholder returns, while making cash generation more sensitive to operating and investment requirements.
Earnings Volatility
The wide swings in profitability across recent years show that earnings have not yet demonstrated a stable long-term pattern. This volatility makes future profit planning less reliable and leaves the company more exposed to another period of weaker operating performance than a consistently expanding peer.
Rising Debt Intensity
Although leverage remains manageable, the increase in debt relative to equity is a clear deterioration from the company’s earlier balance-sheet position. Continued debt growth could reduce financial flexibility, increase funding obligations, and make the improving earnings recovery less resilient during weaker periods.
Vincent Medical Holdings Limited News
Vincent Medical Clarifies Board and Committee Structure Effective August 2026
Vincent Medical Holdings Limited ( ($HK:1612) ) has issued an update. Vincent Medical Holdings Limited has updated its board composition, confirming a mix of executive, non-executive and independent non-executive directors
1612 FAQ
What was Vincent Medical Holdings Limited’s price range in the past 12 months?
What is Vincent Medical Holdings Limited’s market cap?
When is Vincent Medical Holdings Limited’s upcoming earnings report date?
How were Vincent Medical Holdings Limited’s earnings last quarter?
Is Vincent Medical Holdings Limited overvalued?
Does Vincent Medical Holdings Limited pay dividends?
What is Vincent Medical Holdings Limited’s EPS estimate?
How many shares outstanding does Vincent Medical Holdings Limited have?
What happened to Vincent Medical Holdings Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Vincent Medical Holdings Limited?
What is the TipRanks Smart Score and how is it calculated?
Vincent Medical Holdings Limited Stock Smart Score
Company Description
Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing products for other companies (Original Equipment Manufacturing, or OEM) and selling goods under its own proprietary labels (Original Brand Manufacturing). For its OEM clientele, the company specializes in developing respiratory care products, disposable components for imaging contrast media power injectors, and a range of orthopedic and rehabilitation solutions. Its extensive respiratory portfolio encompasses humidification systems, nCPAP interface systems, dedicated respiratory care units, electronic air-oxygen blenders, and anesthesia systems. In the orthopedic and rehabilitation sector, Vincent Medical offers various adjustable braces engineered for post-injury or post-surgical support, protection, and recovery of musculoskeletal areas. The company also pioneers the development of robotic hand training devices. Under its own brand names, including Inspired Medical, Hand of Hope, and Hypnus, Vincent Medical Holdings Limited distributes its offerings across a wide international market. Key regions include the People's Republic of China, the United States, the Netherlands, Australia, and Japan. Established in 1997 and headquartered in Hung Hom, Hong Kong, the company functions as a subsidiary of Vincent Raya International Limited.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Cheung Tai Choi
- Employees
- 1,556
- Website
- www.vincentmedical.com
- Address
- HK
Vincent Medical Holdings Limited (1612) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |









